ABOS - Acumen Pharmaceuticals, Inc.
0.9963
-0.004 -0.371%
Share volume: 114,070
Last Updated: 05-07-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.02%
PREVIOUS CLOSE
CHG
CHG%
$1.00
0.00
0.00%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-14-2024 | 08-08-2023 | 11-13-2023 | 11-12-2024 | 05-14-2024 | 08-13-2024 | 11-12-2024 | 03-27-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | nan% | ||||
| Operating expenses | 13.135 M | 13.478 M | 16.039 M | 18.486 M | 17.774 M | 24.381 M | 32.265 M | 39.597 M | |
| Selling general and admin | 4.422 M | 4.345 M | 4.860 M | 5.193 M | 5.325 M | 4.848 M | 5.018 M | 5.028 M | |
| Research and development | 8.713 M | 9.133 M | 11.179 M | 13.293 M | 12.449 M | 19.533 M | 27.247 M | 34.569 M | |
| Total expenses | 13.135 M | 13.478 M | 16.039 M | 18.486 M | 17.774 M | 24.381 M | 32.265 M | 39.597 M | |
| 2.61% | 19.00% | 15.26% | -3.85% | 37.17% | 32.34% | 22.72% | |||
| Operating income | -13.135 M | -13.478 M | -16.039 M | -18.486 M | -17.774 M | -24.381 M | -32.265 M | -39.597 M | |
| Ebit | -13.139 M | -13.494 M | -16.081 M | -19.867 M | -17.878 M | -23.349 M | -32.242 M | -39.109 M | |
| Pretax income | -11.307 M | -11.610 M | -12.957 M | -16.497 M | -14.873 M | -20.537 M | -29.765 M | -37.154 M | |
| 2.68% | 11.60% | 27.32% | -9.84% | 38.08% | 44.93% | 24.82% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -11.307 M | -11.610 M | -12.957 M | -16.497 M | -14.873 M | -20.537 M | -29.765 M | -37.154 M | |
| -2.68% | -11.60% | -27.32% | 9.84% | -38.08% | -44.93% | -24.82% |
